Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
CAS number: 4651-67-6
Product Code: REF-U01007
Molecular formula: C24H38O4
Molecular weight: 390.56
Purity: 95%+
Product nature: Customized for customers
Appearance: White powder
Storage conditions: 2-8 ℃
Chemical name: (R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Hot Tags:Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。
Synthesis of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1） Reference Standards,
Complex Impurity Of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Chemical Standards of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Characterization Of Unknown Impurities of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Structure Profiling of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Identification of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Isolation & Purification of Impurity of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Difficult of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Instability of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Low-assay of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
Complex Impurity Of Chemical Standards of Urosodeoxycholic Acid EP Impurity F（Obeticholic Acid Intermediate 1）
TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.
China
